Ordering
Available Variants5 mg
CHA.91723-5mg
Price
€65.28
Available – Dispatch in 14 days
25 mg
CHA.91723-25mg
Price
€181.60
Available – Dispatch in 14 days
100 mg
CHA.91723-100mg
Price
€69.00
Available – Dispatch in 14 days
500 mg
CHA.91723-500mg
Price
€271.80
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHA.91723-5mg | €65.28 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
25 mg | CHA.91723-25mg | €181.60 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
100 mg | CHA.91723-100mg | €69.00 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
500 mg | CHA.91723-500mg | €271.80 |
≥98% (HPLC)
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C16H13ClF3NO2 |
|---|---|
| CAS Number | 451491-47-7 |
| Molecular Weight | 343.73 |
| MDL number | MFCD02356522 |
| UNSPSC Code | 12352200 |
| NACRES | NA.77 |
| Assay | ≥98% (HPLC) |
| Form | powder |
| Quality level | 100 |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 2 |
Technical Overview & Applications Use-case context
CTB, also known as 2-(4-Methylpiperazin-1-yl)benzothiazole, is a chemical compound with the CAS registry number 1031262-71-1. It is a benzothiazole derivative that has been studied for its potential biological activities. The compound has been synthesized and characterized using various analytical techniques, including nuclear magnetic resonance spectroscopy and mass spectrometry. CTB has been found to exhibit interesting pharmacological properties, making it a subject of interest in the field of medicinal chemistry. Further research is needed to fully understand the mechanisms of action and potential therapeutic applications of CTB. The compounds chemical structure and properties make it a valuable tool for investigating various biological processes and developing new therapeutic agents. Additional studies are required to explore the full potential of CTB and its potential uses in the pharmaceutical industry.
